Caris Life Sciences, Inc. (CAI)
23.04
-0.92
(-3.84%)
USD |
NASDAQ |
Nov 13, 16:00
23.04
0.00 (0.00%)
After-Hours: 19:59
Caris Life Sciences Total Assets (Quarterly) : 1.256B for Sept. 30, 2026
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 1.256B |
| June 30, 2026 | 1.230B |
| March 31, 2026 | 1.162B |
| December 31, 2025 | 1.126B |
| Date | Value |
|---|---|
| September 30, 2025 | 984.57M |
| June 30, 2025 | 955.06M |
| March 31, 2025 | 291.58M |
| December 31, 2024 | 343.73M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Natera, Inc. | 2.748B |
| Myriad Genetics, Inc. | 609.20M |
| BioRestorative Therapies, Inc. | 4.640M |
| CareDx, Inc. | 641.46M |
| Exagen, Inc. | 55.35M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 616.14M |
| Shareholders Equity (Quarterly) | 639.48M |
| Debt to Equity Ratio | 0.7241 |
| Current Ratio | 6.715 |
| Net Debt Paydown Yield | -0.10% |